Jodi Devlin - 19 May 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Signature
/s/ Mary Szela, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
19 May 2025
Net transactions value
+$100,321
Form type
4
Filing time
21 May 2025, 17:31:57 UTC
Previous filing
19 Feb 2025
Next filing
25 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Devlin Jodi Chief of Clinical Operations 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela, Attorney-in-Fact 21 May 2025 0001992151

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $124,999 +24,131 +72% $5.18 57,528 19 May 2025 Direct F1
transaction TLSI Common Stock Sale $24,678 -4,764 -8.3% $5.18 52,764 19 May 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The granted RSUs vest immediately.
F2 The sale of the shares was to cover the tax liability associated with the granted RSUs.